Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 8 résultats.
    • Article de périodique
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
    • Article de périodique
    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
    • Article de périodique
    Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2 '-deoxycytidine
    Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2001) British Journal of Haematology — Vol. 114, no. 2, p. 349-357 (2001)
    • Communication
    A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients.
    Wijermans, P Ferrant, Augustin[UCL] Lubbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (1998) —
    • Communication
    Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.
    Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) —
    • Article de périodique
    Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
    de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)
    • Communication
    DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).
    Wijermans, P Ferrant, Augustin[UCL] Luebbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc Haak, H (1999) —
    • Article de périodique
    Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
    Wijermans, P Ferrant, Augustin[UCL] Lubbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) Journal of Clinical Oncology — Vol. 18, no. 5, p. 956-962 (2000)